{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hives", "query": { "condition": "Hives" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 221, "total_pages": 23, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hives&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-11T01:42:42.081Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00432510", "title": "Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hereditary Angioedema" ], "interventions": [ { "name": "C1 esterase inhibitor [human] (C1INH-nf)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2006-10-09", "completion_date": "2007-02-28", "has_results": false, "last_update_posted_date": "2021-06-03", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 6, "location_summary": "San Diego, California • Walnut Creek, California • Atlanta, Georgia + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Wheaton", "state": "Maryland" }, { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00432510" }, { "nct_id": "NCT01287117", "title": "A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Idiopathic Urticaria" ], "interventions": [ { "name": "Omalizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 319, "start_date": "2011-02", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2013-11-27", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Huntington Beach, California • Long Beach, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01287117" }, { "nct_id": "NCT00465985", "title": "Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Muckle Wells Syndrome" ], "interventions": [ { "name": "ACZ885", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "4 Years to 75 Years" }, "enrollment_count": 35, "start_date": "2007-04", "completion_date": null, "has_results": true, "last_update_posted_date": "2017-08-28", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 3, "location_summary": "San Francisco, California • Chicago, Illinois • Madison, Wisconsin", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00465985" }, { "nct_id": "NCT06072157", "title": "Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants", "Chronic Spontaneous Urticaria" ], "interventions": [ { "name": "AK006-IV", "type": "DRUG" }, { "name": "Placebo-IV", "type": "DRUG" }, { "name": "AK006-SC", "type": "DRUG" }, { "name": "Placebo-SC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allakos Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 136, "start_date": "2023-08-28", "completion_date": "2025-05-12", "has_results": false, "last_update_posted_date": "2025-06-03", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 19, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Scottsdale, Arizona + 16 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Encino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06072157" }, { "nct_id": "NCT00275795", "title": "NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Food Sensitivities", "Headache", "Backache", "Indigestion", "Eczema, Acne, Hives and Itching of the Skin" ], "interventions": [ { "name": "NAET Procedures", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Nambudripad's Allergy Research Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "78 Years", "sex": "ALL", "summary": "2 Years to 78 Years" }, "enrollment_count": 42, "start_date": "2005-07", "completion_date": "2006-01", "has_results": false, "last_update_posted_date": "2006-11-01", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 1, "location_summary": "Buena Park, California", "locations": [ { "city": "Buena Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00275795" }, { "nct_id": "NCT00094900", "title": "Interleukin-1 Trap to Treat Autoinflammatory Diseases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Inflammation", "Familial Mediterranean Fever", "Still's Disease, Adult-Onset" ], "interventions": [ { "name": "IL-1 Trap", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2004-10", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2014-03-04", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00094900" }, { "nct_id": "NCT03410290", "title": "Journey of Patients With Vasculitis From First Symptom to Diagnosis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Vasculitis", "Systemic Vasculitis", "Behcet's Disease", "CNS Vasculitis", "Cryoglobulinemic Vasculitis", "Eosinophilic Granulomatous Vasculitis", "Temporal Arteritis", "Giant Cell Arteritis", "Granulomatosis With Polyangiitis", "Wegener Granulomatosis", "Henoch Schonlein Purpura", "IgA Vasculitis", "Microscopic Polyangiitis", "Polyarteritis Nodosa", "Takayasu Arteritis", "Urticarial Vasculitis" ], "interventions": [ { "name": "Online Questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 456, "start_date": "2018-01-11", "completion_date": "2018-05-21", "has_results": false, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03410290" }, { "nct_id": "NCT06077773", "title": "Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Spontaneous Urticaria" ], "interventions": [ { "name": "Oral EP262", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Escient Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 113, "start_date": "2023-09-25", "completion_date": "2025-01-16", "has_results": true, "last_update_posted_date": "2025-12-19", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 34, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06077773" }, { "nct_id": "NCT06974877", "title": "Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cryopyrin-Associated Periodic Syndromes", "Amyloidosis" ], "interventions": [ { "name": "124I AT-01", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 30, "start_date": "2025-09-10", "completion_date": "2032-01-31", "has_results": false, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06974877" }, { "nct_id": "NCT02620254", "title": "Mast Cell Connect: A Registry for Patients With Mastocytosis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mastocytosis" ], "interventions": [], "intervention_types": [], "sponsor": "Blueprint Medicines Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 743, "start_date": "2015-11", "completion_date": "2021-01", "has_results": false, "last_update_posted_date": "2021-02-04", "last_synced_at": "2026-06-11T01:42:42.081Z", "location_count": 1, "location_summary": "Cambridge, Massachusetts", "locations": [ { "city": "Cambridge", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02620254" } ] }